alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**Exhibit 31.1**

 

**Certificationof Chief Executive OfficerRequired by Rule 13a-14(a) (17 CFR 240.13a-14(a))**

 

I, Christopher B. Begley,certify that:

 

1.  I have reviewed this quarterly report on Form 10-Qof Hospira, Inc. (“Hospira”);

 

2.  Based on my knowledge, this report does notcontain any untrue statement of a material fact or omit to state a materialfact necessary to make the statements made, in light of the circumstances underwhich such statements were made, not misleading with respect to the period coveredby this report;

 

3.  Based on my knowledge, the financialstatements, and other financial information included in this report, fairlypresent in all material respects the financial condition, results of operationsand cash flows of Hospira as of, and for, the periods presented in this report;

 

4.  Hospira’s other certifying officer and I areresponsible for establishing and maintaining disclosure controls and procedures(as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) forHospira, and have:

 

a)Designed such disclosure controls and procedures, or caused such disclosurecontrols and procedures to be designed under our supervision, to ensure thatmaterial information relating to Hospira, including its consolidatedsubsidiaries, is made known to us by others within those entities, particularlyduring the period in which this report is being prepared;

 

b)Evaluated the effectiveness of Hospira’s disclosure controls and procedures andpresented in this report our conclusions about the effectiveness of thedisclosure controls and procedures, as of the end of the period covered by thisreport based on such evaluation; and

 

c)Disclosed in this report any change in Hospira’s internal control overfinancial reporting that occurred during Hospira’s most recent fiscal quarterthat has materially affected, or is reasonably likely to materially affect,Hospira’s internal control over financial reporting; and

 

5.  Hospira’s other certifying officer and I havedisclosed, based on our most recent evaluation of internal control overfinancial reporting, to Hospira’s auditors and the audit and public policycommittee of Hospira’s board of directors:

 

a)All significant deficiencies and material weaknesses in the design or operationof internal control over financial reporting which are reasonably likely toadversely affect Hospira’s ability to record, process, summarize and reportfinancial information; and

 

b)Any fraud, whether or not material, that involves management or other employeeswho have a significant role in Hospira’s internal control over financialreporting.

 

 
| Date: November 10,  2005 | /s/  Christopher B.  Begley                |   |
|-------------------------------|-------------------------------------------------|--------|
|                          | Christopher B. Begley,  Chief Executive Officer |

 

1

----
# L_2016041EN.01002201.xml

| 18.2.2016 | EN | Official Journal of the European Union | L 41/22 |
| --- | --- | --- | --- |

18.2.2016

EN

Official Journal of the European Union

L 41/22

---

COUNCIL DECISION (EU) 2016/229

of 16 February 2016

appointing a member, proposed by the Kingdom of Denmark, of the European Economic and Social Committee

THE COUNCIL OF THE EUROPEAN UNION,

Having regard to the Treaty on the Functioning of the European Union, and in particular Article 302 thereof,

Having regard to the proposal of the Danish Government,

Having regard to the opinion of the European Commission,

Whereas:

| (1) | On 18 September 2015 and 1 October 2015, the Council adopted Decisions (EU, Euratom) 2015/1600 (1) and 2015/1790 (2) appointing the members of the European Economic and Social Committee for the period from 21 September 2015 to 20 September 2020. |
| --- | --- |

(1)

On 18 September 2015 and 1 October 2015, the Council adopted Decisions (EU, Euratom) 2015/1600 (1) and 2015/1790 (2) appointing the members of the European Economic and Social Committee for the period from 21 September 2015 to 20 September 2020.

| (2) | A member's seat on the European Economic and Social Committee has become vacant following the end of the term of office of Ms Marie-Louise KNUPPERT, |
| --- | --- |

(2)

A member's seat on the European Economic and Social Committee has become vacant following the end of the term of office of Ms Marie-Louise KNUPPERT,

HAS ADOPTED THIS DECISION:

Article 1

Mr Arne GREVSEN, First Vice-President of the Danish Confederation of Trade Unions (LO), is hereby appointed as a member of the European Economic and Social Committee for the remainder of the current term of office, which runs until 20 September 2020.

Article 2

This Decision shall enter into force on the date of its adoption.

Done at Brussels, 16 February 2016.

For the Council

The President

A.G. KOENDERS

---

(1)  Council Decision (EU, Euratom) 2015/1600 of 18 September 2015 appointing the members of the European Economic and Social Committee for the period from 21 September 2015 to 20 September 2020 (OJ L 248, 24.9.2015, p. 53).

1

(2)  Council Decision (EU, Euratom) 2015/1790 of 1 October 2015 appointing the members of the European Economic and Social Committee for the period from 21 September 2015 to 20 September 2020 (OJ L 260, 7.10.2015, p. 23).

2

---
JG WINSTON-SALEM, LLC v. CENTRAL CAROLINA SURGICAL EYE ASSOCIATES, P.A..

No. COA03-1515.

Court of Appeals of North Carolina.

Filed July 6, 2004.

Certification Date July 26, 2004.

Case reported without published opinion. Appeal dismissed.
In the Matter of A.K. appealed by Respondent Father.

No. 139PA05.

Supreme Court of North Carolina.

June 30, 2005.

Richard Croutharmel, for Robert K.

Charlotte Wade, for Buncombe County DSS.

Michael Tousey, for Buncombe County GAL.

Elizabeth Spradlin, for Mother.

*ORDER*

Upon consideration of the petition filed on the 9th day of March 2005 by Respondent (Father) in this matter for discretionary review of the decision of the North Carolina Court of Appeals pursuant to G.S. 7A-31, the following order was entered and is hereby certified to the North Carolina Court of Appeals:

"Allowed by order of the Court in conference, this the 30th day of June 2005."

Therefore the case is docketed as of the date of this order's certification. Briefs of the respective parties shall be submitted to this Court within the times allowed and in the manner provided by Appellate Rule 15(g)(2).
EXHIBIT 32.2

CERTIFICATION OF CFO PURSUANT TO  18 U.S.C. SECTION 1350,  AS ADOPTED PURSUANT TO  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of NorthStar Realty Finance Corp. (the "Company") for the
quarterly period ended June 30, 2009 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), Andrew C. Richardson, as Chief Financial Officer of the Company,
hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of his knowledge:



Date: August 4, 2009

By:

/s/ ANDREW C. RICHARDSON Andrew C. Richardson Chief Financial Officer


This
certification accompanies the Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002,
be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

A
signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the Company and will be retained by the Company and
furnished to the Securities and Exchange Commission or its staff upon request.

---



QuickLinks
Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350

In connection with the accompanying quarterly report on Form 10-Q of Superior Essex Inc. (the
"Company") for the period March 31, 2004 (the "Periodic Report"), I, David S. Aldridge, Chief
Financial Officer of the Company, hereby certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge and
belief, that the Periodic Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that the information contained in the Periodic Report
fairly presents, in all material respects, the financial condition and results of operations of the Company.

|Date: May 14, 2004 |  | /s/DAVID S. ALDRIDGEDavid S. Aldridge
Executive Vice President, Chief Financial Officer and Treasurer
|------------------ |  | -----------------------------------------------------------------------------------------------------

---



QuickLinks
STATE v. BROWN.

No. COA04-384.

Court of Appeals of North Carolina.

Filed April 19, 2005.

Certification Date May 9, 2005.

Appeal from Moore (01CRS51438).

Case reported without published opinion. No error.
Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

Each of the undersigned hereby certifies that this Quarterly Report on Form 10-Q fully complies with the requirements of
Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and the information contained in such report fairly presents, in all material respects, the financial condition and results of operations of Bank of the James Financial
Group, Inc.



|                   |  |  |  |                                         |  |                                                                                                        
|------------------ |  |  |  | --------------------------------------- |  | -------------------------------------------------------------------------------------------------------
|                   |  |  |  | BANK OF THE JAMES FINANCIAL GROUP, INC.
|                   |  |  | 
|Date: May 12, 2010 |  |  |  | By                                      |  | /S/ Robert R. Chapman III                                                                              
|                   |  |  |  |                                         |  | Robert R. Chapman III, President
(Principal Executive Officer)                                         
|                   |  |  | 
|Date: May 12, 2010 |  |  |  | By                                      |  | /S/ J. Todd Scruggs                                                                                    
|                   |  |  |  |                                         |  | J. Todd Scruggs, Secretary and Treasurer
(Principal Financial Officer and Principal Accounting Officer)



32
```

[Congressional Bills 110th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5092 Introduced in House (IH)]

110th CONGRESS
  2d Session
                                H. R. 5092

 To extend the temporary suspension of duty on acrylic or modoacrylic 
staple fibers, not carded, combed, or otherwise processed for spinning.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                            January 22, 2008

  Mr. Coble introduced the following bill; which was referred to the 
                      Committee on Ways and Means

_______________________________________________________________________

                                 A BILL

 
 To extend the temporary suspension of duty on acrylic or modoacrylic 
staple fibers, not carded, combed, or otherwise processed for spinning.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. ACRYLIC OR MODOACRYLIC STAPLE FIBERS, NOT CARDED, COMBED, OR 
              OTHERWISE PROCESSED FOR SPINNING.

    (a) In General.--Heading 9902.25.62 of the Harmonized Tariff 
Schedule of the United States (relating to acrylic or modoacrylic 
staple fibers, not carded, combed, or otherwise processed for spinning) 
is amended by striking ``12/31/2009'' and inserting ``12/31/2011''.
    (b) Effective Date.--The amendment made by subsection (a) applies 
to goods entered, or withdrawn from warehouse for consumption, on or 
after the 15th day after the date of the enactment of this Act.
                                 <all>
```
Exhibit 32.2



QUADRAMED CORPORATION

SECTION 1350 CERTIFICATIONS



In connection with this Annual Report on Form 10-K of QuadraMed Corporation for the period ended December 31, 2006, I, David L. Piazza, Chief Financial Officer of QuadraMed Corporation, hereby certify pursuant to 18 U.S.C. 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my best knowledge:



|3. | This Form 10-K for the period ended December 31, 2006 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|-- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------



|4. | The information contained in this Form 10-K for the period ended December 31, 2006 fairly presents, in all material respects, the financial condition and results of operations
of QuadraMed Corporation.
|-- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



|                     |  |                        
|-------------------- |  | -----------------------
|Date: March 16, 2007 |  | /s/ David L. Piazza    
|                     |  | David L. Piazza        
|                     |  | Chief Financial Officer
```

[Congressional Bills 110th Congress]
[From the U.S. Government Publishing Office]
[H.R. 4862 Introduced in House (IH)]

110th CONGRESS
  1st Session
                                H. R. 4862

 To extend the temporary suspension of duty on 2,4-Disulfobenzaldehyde.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                           December 19, 2007

   Mr. Clay introduced the following bill; which was referred to the 
                      Committee on Ways and Means

_______________________________________________________________________

                                 A BILL

 
 To extend the temporary suspension of duty on 2,4-Disulfobenzaldehyde.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. 2,4-DISULFOBENZALDEHYDE.

    (a) In General.--Heading 9902.01.66 of the Harmonized Tariff 
Schedule of the United States is amended by striking ``12/31/2009'' and 
inserting ``12/31/2011''.
    (b) Effective Date.--The amendment made by subsection (a) applies 
with respect to goods entered, or withdrawn from warehouse for 
consumption, on or after the 15th day after the date of the enactment 
of this Act.
                                 <all>
```
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
REGISTRANT'S CONDENSED CONSOLIDATED FINANCIAL STATEMENTS AS OF AND FOR THE THREE
MONTHS ENDED MARCH 31, 1997 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO
SUCH INTERIM CONSOLIDATED FINANCIAL STATEMENTS.
</LEGEND>
<RESTATED>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             JAN-01-1997
<PERIOD-END>                               MAR-31-1997
<CASH>                                          14,020
<SECURITIES>                                         0
<RECEIVABLES>                                    5,405
<ALLOWANCES>                                         0
<INVENTORY>                                     14,742
<CURRENT-ASSETS>                                36,567
<PP&E>                                           3,684
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                 046,246
<CURRENT-LIABILITIES>                            5,918
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                            52
<OTHER-SE>                                      39,075
<TOTAL-LIABILITY-AND-EQUITY>                    46,246
<SALES>                                          9,585
<TOTAL-REVENUES>                                 9,585
<CGS>                                            4,360
<TOTAL-COSTS>                                    4,093
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                  1,248
<INCOME-TAX>                                       438
<INCOME-CONTINUING>                                810
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       810
<EPS-PRIMARY>                                     0.16
<EPS-DILUTED>                                     0.15


</TABLE>
**EXHIBIT 31.1**

**CERTIFICATIONS**

I,Joseph Ram, Chief Executive Officer of InfoSonics Corporation, certify that:

1.               Ihave reviewed this Quarterly Report on Form 10-Q of InfoSonics Corporation;

2.               Basedon my knowledge, this report does not contain any untrue statement of amaterial fact or omit to state a material fact necessary to make the statementsmade, in light of the circumstances under which such statements were made, notmisleading with respect to the period covered by this report;

3.               Basedon my knowledge, the financial statements, and other financial informationincluded in this report, fairly present in all material respects the financialcondition, results of operations and cash flows of the registrant as of, andfor, the periods presented in this report;

4.               Theregistrant’s other certifying officer(s) and I are responsible for establishingand maintaining disclosure controls and procedures (as defined in Exchange ActRules 13a-15(e) and 15d-15(e)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosurecontrols and procedures to be designed under our supervision, to ensure thatmaterial information relating to the registrant, including its consolidatedsubsidiaries, is made known to us by others within those entities, particularlyduring the period in which this report is being prepared;

(b)Evaluated the effectiveness of the registrant’s disclosure controls andprocedures and presented in this report our conclusions about the effectivenessof the disclosure controls and procedures, as of the end of the period coveredby this report based on such evaluation; and

(c)Disclosed in this report any change in the registrant’s internal control overfinancial reporting that occurred during the registrant’s most recent fiscalquarter (the registrant’s fourth fiscal quarter in the case of an annualreport) that has materially affected, or is reasonably likely to materiallyaffect, the registrant’s internal control over financial reporting;

5.               Theregistrant’s other certifying officer(s) and I have disclosed, based on ourmost recent evaluation of internal control over financial reporting, to theregistrant’s auditors and the audit committee of the registrant’s board ofdirectors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operationof internal control over financial reporting which are reasonably likely toadversely affect the registrant’s ability to record, process, summarize and reportfinancial information; and

(b)Any fraud, whether or not material, that involves management or other employeeswho have a significant role in the registrant’s internal control over financialreporting.

 
| Date: November 14, 2006 | /s/ Joseph  Ram                 |
|-------------------------|--------------------------------------|
|                    | Joseph  Ram, Chief Executive Officer |

 

----
**Exhibit 32.1**

PHARMACOPEIA, INC.

CERTIFICATION

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF2002

In connection with the Quarterly Report of Pharmacopeia, Inc. (the “Company”)on Form 10-Q for the period ended June 30, 2007, as filed with theSecurities and Exchange Commission on the date hereof (the “Report”), I, LeslieJ. Browne, Ph.D., President and Chief Executive Officer of the Company, herebycertify pursuant to 18 U.S.C. Section 1350, as adopted pursuant toSection 906 of the Sarbanes-Oxley Act of 2002, that:

(1)  The Report fully complies with the requirements ofSection 13(a) or 15(d) of the Securities Exchange Act of 1934;and

(2)  The information contained in the Report fairly presents, inall material respects, the financial condition and results of operations of theCompany.
| By:    | /s/ Leslie J. Browne, Ph.D.                     |   |   |
|--------|-------------------------------------------------|--------|--------|
|   | Leslie J. Brown, Ph.D.                          |   |
|   | President, Chief Executive Officer and Director |   |
|   | (Principal Executive Officer)                   |   |
|   | August 2, 2007                                  |   |

 

----
EXHIBIT 31.1

                                  CERTIFICATION

I,  Theodore G. Hollinger, Chief Executive Officer, certify that:

     1.  I have reviewed this quarterly report on Form 10-QSB of Hydrogen Engine
         Center, Inc.;

     2.  Based  on my  knowledge,  this  report  does  not  contain  any  untrue
         statement of a material fact or omit to state a material fact necessary
         to make the statements made, in light of the circumstances  under which
         such  statements  were made, not misleading  with respect to the period
         covered by this report;

     3.  Based on my knowledge,  the financial  statements,  and other financial
         information  included in this  report,  fairly  present in all material
         respects the financial condition,  results of operations and cash flows
         of the registrant as of, and for, the periods presented in this report;

     4.  The registrant's other certifying  officer and I have disclosed,  based
         on our most  recent  evaluation  of  internal  control  over  financial
         reporting,  to the registrant's auditors and the audit committee of the
         registrant's  board of directors (or persons  performing the equivalent
         functions):

         a.   All significant deficiencies and material weaknesses in the design
              or operation of internal  control over financial  reporting  which
              are reasonably likely to adversely affect the registrant's ability
              to record,  process,  summarize and report financial  information;
              and

         b.   Any fraud,  whether or not material,  that involves  management or
              other  employees who have a significant  role in the  registrant's
              internal control over financial reporting.

 November 21, 2005                           /s/ Theodore G. Hollinger
                                             -----------------------------------
                                             Theodore G. Hollinger
                                             Chief Executive Officer